Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
Curebase Unlocks Drug Development with Remote Clinical Trials; Raises $15m Led by GGV Capital
Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial […]
Verana Health Leads First-of-its-Kind Study Demonstrating Promise of Real-World Data in Ophthalmic Clinical Development
Verana Health, a healthcare technology and analytics innovator transforming multi-specialty clinical data into real-world evidence, […]
Nearly Half of All Clinical Research Will Adopt Decentralized Clinical Trials Within Next Twelve Months, Survey Finds
VivaLNK, a leading provider of connected healthcare solutions, today announces the results of a survey of pharma, […]
World-first Covid-19 Vaccine Booster Study Launches in UK
Thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial launching […]
Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial
The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates of neutralizing antibody […]
Exscientia Announces Second Molecule Created Using AI from Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trial
Exscientia Ltd. (Headquarters: Oxford, UK; CEO: Andrew Hopkins) is pleased to acknowledge that Sumitomo Dainippon Pharma Co., […]
NHS’s £160M Accelerator Sites to Tackle Waiting Lists
The NHS has today announced a £160 million initiative to tackle waiting lists and develop […]
Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate (NanoFlu/NVX-CoV2373)
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]
STRIDES Study Reaches Million-donor Milestone
The NHS Blood and Transplant (NHSBT) blood donor management research project, STRIDES, now has more […]
GSK and VIR Biotechnology EMA Rolling Review of VIR-7831 (Sotrovimab)
GlaxoSmithKline plc and Vir Biotechnology, Inc. today announced that the European Medicines Agency (EMA) has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more